Novel Exercise May Aid Rheumatoid Arthritis Outcomes
TUESDAY, July 8, 2025 -- A novel form of upper- and lower-body exercise, blood flow-restricted resistance training (BFR-RT), improves outcomes with rheumatoid arthritis (RA), according to research recently published in Disability and Rehabilitation.
Hunter Bennett, Ph.D., from the University of South Australia in Adelaide, and colleagues assessed the acceptability and impact of a progressive upper- and lower-body BFR-RT intervention. The analysis included a cross-sectional survey examining exercise preferences of 97 people with RA and a single-group trial of 12 participants.
The researchers found that people with RA preferred BFR-RT if it was supervised by an exercise professional, was no more than three sessions per week, and began with low-to-moderate intensity. The BFR-RT trial aligned with the survey results and had high acceptability, with 100 percent of participants liking the program and 81 percent adhering to the sessions. The trial showed significant improvements in strength, functional lower extremity-related physical performance, and perceived pain. There were no improvements in quality of life noted.
"This kind of training could be a game changer for people with rheumatoid arthritis," Bennett said in a statement. "It offers a way to build strength and reduce pain without pushing through discomfort -- and that's incredibly empowering for people who've often been limited by their condition."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Read this next
Cancer Survival Lower in Rural Areas
WEDNESDAY, Oct. 1, 2025 -- Five-year cancer survival rates for each stage of cancer (localized, regional, and distant) is lower in nonmetropolitan areas for Black and White...
Loss of Smell May Linger After COVID-19
WEDNESDAY, Oct. 1, 2025 -- Self-reported change or loss in smell or taste is an accurate signal of verified hyposmia after COVID-19, although there is also a high rate of hyposmia...
Elderly Patients Benefit From Screening Mammography
WEDNESDAY, Oct. 1, 2025 -- Patients with breast cancer diagnosed at 80 years of age or older who received screening mammography present with earlier-stage disease and have better...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.